Objective: Intrathoracic subclavian artery aneurysms (SAAs) are rare aneurysms that often occur in association with congenital aortic arch anomalies and/or concomitant thoracic aortic pathology. The advent of thoracic endovascular aortic repair (TEVAR) methods may complement or replace conventional open SAA repair. Herein, we describe our experience with SAA repair in the TEVAR era. Methods: A retrospective review was performed of all intrathoracic SAAs repaired at a single institution since United States Food and Drug Administration approval of TEVAR in 2005. Results: Nineteen patients underwent 20 operations to repair 22 (13 native, nine aberrant) SAAs with an intrathoracic component. Mean SAA diameter was 3.1 cm (range, 1.6-6.0 cm). Mean patient age was 57 years (range, 24-80 years). Twenty-one percent (n [ 4) of patients had a connective tissue disorder (two Loeys-Dietz, two Marfan). Thirty-six percent (n [ 8) of SAAs were repaired by open techniques and 64% (n [ 14) via a TEVAR-based approach. All TEVAR cases required proximal landing zone in the aortic arch (zone 0-2), and revascularization of at least one arch vessel was required in 83% (10/12) of patients. Concomitant repair of associated aortic pathology was performed in 50% (n [ 10) of operations. Thirty-day/in-hospital rates of death, stroke, and permanent paraplegia/paraparesis were 5% (n [ 1), 5% (n [ 1), and 0%, respectively. Over mean (standard deviation) follow-up of 24 (21) months, 16% (n [ 3) of patients required reintervention for subclavian artery bypass graft revision (n [ 2) or type II endoleak (n [ 1). Conclusions: This is the largest single-institution series to date of TEVAR for SAA repair. Modern endovascular techniques expand SAA repair options with excellent results. The majority of SAAs and nearly all aberrant SAAs (Kommerell's diverticulum) can now be repaired using a TEVAR-based approach without the need for sternotomy or thoracotomy. (J Vasc Surg 2013;57:915-25.) 
Intrathoracic subclavian artery aneurysms (SAAs) are rare peripheral arterial aneurysms that are repaired to prevent rupture or treat symptoms of thrombosis, embolization, pain, or local compression. 1 The surgical approach to SAA repair is often complex and is challenged by the presence of congenital aortic arch anomalies, concomitant aortic pathology, prior aortic interventions, patient comorbid conditions, and/or hereditary connective tissue disease (CTD). 2 Conventional open SAA repair requires sternotomy or thoracotomy for access and in a recent meta-analysis was associated with a mortality rate of 8% and a complication rate of 26%. 1 In the present era, many SAAs can be repaired by minimally invasive endovascular or "hybrid" open/endovascular techniques, which may allow for repair with reduced morbidity. 1 The availability of thoracic endovascular aortic repair (TEVAR) in 2005 provided an additional tool for the treatment of complex thoracic aortic pathology. Reports of TEVAR for SAA repair are limited to case reports, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] and no single-institution series has specifically explored the role of TEVAR for SAA repair. We therefore sought to review our institutional experience with SAA repair since United States Food and Drug Administration approval of TEVAR in March 2005 and present our surgical approach to SAA repair using both open and TEVAR-based endovascular techniques. In this article, the term "native" is used to refer to a nonaberrant subclavian artery arising from the normal anatomic position on the aortic arch. Aortic arch landing zones were defined using the Ishimaru classification. 22 Comorbid conditions and postoperative complications were defined using Society of Thoracic Surgeons definitions (www.sts. org). Indications for SAA repair included size >2.0 cm, symptoms, or size >1.5 cm and concurrent operation for other aortic pathology. Open proximal thoracic aortic operations were performed as previously described. [23] [24] [25] Techniques of TEVAR device delivery and deployment and of postoperative surveillance have been described previously. 21, 26, 27 All thoracic endografts commercially available during the study period were used and included the Gore TAG and C-TAG (W. L. Gore & Associates, Flagstaff, Ariz), Medtronic Talent (Medtronic Inc, Santa Rosa, Calif), and Zenith TX2 (Cook Medical Inc, Bloomington, Ind) devices. Primary technical success was defined according to Society for Vascular Surgery reporting standards. 28 Patient survival and subclavian artery bypass graft patency were assessed from the electronic medical record. Subclavian artery bypass graft patency at most recent follow-up was determined based on imaging findings. Life status was assessed for patients lost to follow-up using the Social Security Death Database.
Statistical analysis. Continuous and categorical variables were compared between groups using the Mann-Whitney test and the c 2 test, respectively. Estimates of subclavian artery bypass graft patency and reintervention rates were calculated using the Kaplan-Meier method using the date of the most recent clinic visit with computed tomographic angiography to define the follow-up interval. Survival rates were calculated using the Kaplan-Meier method. Patients were presumed to be living unless medical record or the Social Security Death Database confirmed death. Calculations were performed using SPSS 19.0.0 (IBM SPSS Statistics, Chicago, Ill).
Operative techniques
Native left SAA repair-endovascular approach. An endovascular approach was used in patients with a native left SAA without concomitant aortic pathology requiring open repair (Fig 1) . Selective left subclavian artery (LSCA) revascularization (8-mm polytetrafluoroethylene graft) was performed at the time of the TEVAR procedure based on previously established indications and institutional protocols. 20 Proximal exclusion of the LSCA was accomplished by deployment of the aortic endograft with LSCA coverage. Distal SAA exclusion was accomplished by ligation, coil embolization, or placement of an Amplatzer Vascular Plug (St. Jude Medical Inc, St. Paul, Minn) via left brachial access.
Native left SAA repair-open approach. Open left SAA repair was reserved primarily for patients requiring concomitant extensive aortic replacement due to CTD or "mega aorta syndrome." 29, 30 In all cases except one, a total arch replacement (stage I elephant trunk procedure) was performed first using a modified Mt. Sinai technique. 25, 30 If the LSCA arose proximally enough from the aortic arch such that it could be reached via sternotomy, then the aneurysmal LSCA was ligated and bypassed during total arch replacement (Fig 2, A) . In patients in whom the LSCA arose too distally from the arch to be addressed via sternotomy, the left SAA was excluded by descending aorta to LSCA bypass at the time of open stage II thoracoabdominal aortic aneurysm (TAAA) repair (Fig 2, B and C). 31 Aberrant left SAA repair. The aberrant left SAAs (Kommerell's diverticulum) in this series occurred in patients with right-sided aortic arches and right descending thoracic aortas and were treated by endovascular methods. Proximal exclusion of the aberrant LSCA was accomplished by endograft coverage of the LSCA orifice. Distal SAA exclusion was accomplished by coil embolization or vascular plug occlusion via left brachial access (Fig 3) .
Native right SAA repair. The native right SAAs encountered in this series did not involve the innominate artery and were repaired by open bypass at the time of concurrent arch repair or interposition grafting via median sternotomy (Fig 4) . Aberrant right SAA repair. Aberrant right SAAs (Kommerell's diverticulum) were repaired using endovascular methods ( Fig 5) . Given the proximity of the aberrant right subclavian artery (RSCA) to the other arch vessels, isolated endograft coverage of the RSCA orifice was not possible, and zone 2-zone 0 endograft coverage was required to achieve adequate proximal landing zone, yielding bilateral subclavian artery coverage in all cases. As such, at least one subclavian artery was revascularized in all cases, and bilateral subclavian artery revascularization was performed if indicated. 20 For cases requiring zone 1 endograft coverage, a carotid-carotid bypass was performed to revascularize the left common carotid artery (LCCA) before LCCA coverage by the endograft. For cases requiring zone 0 endograft coverage, ascending aorta-based arch debranching was performed via median sternotomy to revascularize the right common carotid artery (RCCA) and LCCA before endograft coverage. 25, 30 Table I . Operative characteristics for SAA repair stratified by anatomic subtype are given in Tables II-V. Thirty-day/in-hospital outcomes are listed in Table VI 
RESULTS

Patient demographics are listed in
Operative details
Native left SAA repair-endovascular approach. Five patients underwent native left SAA repair via a totally endovascular or hybrid approach (Table II) . Repair was achieved exclusively by endovascular methods in one patient (no. 1) by LSCA endograft coverage and endovascular distal aneurysm occlusion (Fig 1, B) . Repair was achieved by the same method in a second patient (no. 2), but LSCA revascularization was required due to symptoms of arm ischemia after endograft deployment (Fig 1, C) . The third patient (no. 3) underwent vascular plug occlusion of a left SAA, followed by proximal LSCA endovascular coverage 9 months later at the time of hybrid TAAA repair for a rapidly enlarging TAAA. 32 The remaining two patients (no. 4 and 5) had bilateral SAAs (native left SAA and aberrant right SAA) that were repaired by endograft coverage of the two neighboring subclavian arteries ( Fig 5, B and C) . Patient no. 4 had previously undergone aberrant right SAA distal ligation with RCCA to RSCA bypass at an outside institution, although the residual aberrant right SAA stump continued to be pressurized, via the vessel origin from the aorta, and aneurysmal. LSCA revascularization was performed in this patient to preserve unilateral vertebral artery perfusion given that the right vertebral artery had been sacrificed during the previous RSCA ligation. This patient also harbored a 5.1-cm proximal descending thoracic aortic aneurysm that was excluded by the endograft. Patient no. 5 underwent aberrant right SAA repair by endograft coverage and vascular plug occlusion, and later underwent native left SAA repair by placement of a proximal extension cuff and LSCA vascular plug during a second procedure given interval left SAA growth.
Native left SAA-open approach. Six patients underwent open repair of a native left SAA (Table II) ( Fig 2, A) . 33 Three patients (no. 8, 9, and 10) with CTD underwent left SAA resection and bypass via left thoracotomy at the time of open TAAA repair after stage I total arch replacement. In all of these patients, the LSCA arose too far distally on the aortic arch to be addressed via median sternotomy at the time of the first stage total arch replacement (Fig 2, B) . The final patient (no. 11) presented with complete thrombosis of a native left SAA leading to left hand emboli and ischemia. She underwent open LCCA to brachial artery bypass with distal aneurysm ligation to exclude the aneurysm and revascularize the left upper extremity.
Aberrant left SAA. Two patients underwent aberrant left SAA (Kommerell's diverticulum) repair via a totally endovascular or hybrid approach (Table III) . The first patient (no. 12) underwent urgent total endovascular repair of a symptomatic aberrant left SAA by LSCA coverage and distal plug occlusion without LSCA revascularization (Fig 3, B) . The second patient (no. 13) required a zone 0 ascending aorta proximal landing zone to obtain adequate proximal seal, which was performed via median sternotomy for ascending aorta to LCCA, RCCA, and left axillary bypass using a trifurcated graft.
Native right SAA. Two patients underwent open repair of a native right SAA (Table IV ). The first was the aforementioned patient (no. 6) with Marfan syndrome who had bilateral native SAAs that were repaired by ligation and bypass during total arch replacement. The second patient (no. 14) underwent median sternotomy and RSCA interposition grafting with an 8-mm polyester (Dacron) graft (endoaneurysmorrhaphy; Fig 4, B) .
Aberrant right SAA. Seven patients underwent aberrant right SAA (Kommerell's diverticulum) repair via a totally endovascular or hybrid approach (Table V) . The first two were the aforementioned patients (no. 4 and 5) with bilateral native left and aberrant right SAAs that were repaired by endograft coverage of the neighboring subclavian arteries ( Fig 5, B and C) . RSCA revascularization was previously performed in the first patient (no. 4) and was not necessary in the second patient (no. 5) given LCCA to LSCA bypass in the setting of bilateral subclavian artery endograft coverage. One patient (no. 15) experienced an acute type B aortic dissection with contained rupture and extension of the dissection into an aneurysmal aberrant right SAA. He required bilateral subclavian artery coverage to cover the primary dissection tear and later underwent open aberrant right SAA ligation because of type II endoleak, and bilateral carotid-subclavian bypass because of symptoms of vertebrobasilar insufficiency.
One additional patient (no. 16) required zone 1 endograft placement to achieve proximal seal (Fig 5, C) , and two patients required zone 0 endograft coverage in order to treat concurrent transverse arch pathology (no. 17) or achieve adequate proximal seal (no. 18). Urgent repair was required in the latter patient (no. 18) due to aberrant right SAA erosion into the posterior The great vessels off of the arch were implanted into the Dacron arch graft using an island technique. The patient underwent a visceral debranching hybrid TAAA repair 5 years later at our institution, with proximal landing zone in the elephant trunk graft. The aberrant right SAA arising from the proximal descending thoracic aorta was excluded by completion endografting and distal vascular plug occlusion (Fig 7) .
Thirty-day/in-hospital outcomes. All patients survived to hospital discharge. One patient (no. 18) died after hospital discharge but within 30 days of surgery due to respiratory failure after urgent zone 0 hybrid arch repair, yielding a 30-day/in-hospital mortality rate of 5% (0% elective, 33% nonelective). One patient with an aberrant left SAA and right descending thoracic aorta (no. 13) experienced a perioperative stroke, and no cases of paraplegia were observed (Table VI) .
Subclavian artery bypass graft patency, reinterventions, and survival. Mean clinic follow-up was 24 (21) months (median, 18 months) with 21% (4/19) of patients lost to follow-up. During the follow-up interval, 16% (n ¼ 3) of patients required reintervention (Fig 6,  A) . Both patients with native right SAAs required reintervention. The first patient (no. 6) experienced acute thrombosis of the RSCA to right brachial artery bypass graft on postoperative day 12 and required a Fogarty thrombectomy. The second patient (no. 14) experienced RSCA interposition graft thrombosis 6 months after repair and underwent RCCA to right axillary bypass with Fig 6,  B) . Secondary patency was 100% as all subclavian artery bypass grafts were patent at most recent follow-up. Kaplan-Meier estimates of survival for the entire patient cohort were 95% and 73% at 1 and 3 years, respectively (P ¼ .59; Fig 6, C) .
DISCUSSION
In this study, we detail our recent experience with SAA repair since the advent of TEVAR using open, totally endovascular, and hybrid techniques. The present cohort of 19 patients with 22 SAAs represents one of the largest single-institution reports of SAA repair in the literature and the largest series of patients with SAA to be treated using TEVAR. 1 In total, 36% (n ¼ 8) of SAAs were repaired by open techniques and 64% (n ¼ 14) were repaired via a TEVAR-based approach. Of the 12 patients with 14 SAAs repaired by TEVAR, repair was achieved by totally endovascular techniques in 17% (n ¼ 2) of patients and by hybrid techniques in 83% (n ¼ 10) of patients. The outcomes of SAA repair appeared favorable and were comparable with prior reports. 1 SAAs are rare entities that comprise 0.5% of all aneurysm repairs in the United States. 34 However, SAAs are perhaps 200 to 3000 times more likely to occur in patients with other peripheral aneurysms or aortic pathology. Dent et al 35 reported SAA repairs were performed in 0.0007% (2/287,448) of individuals in the general hospital population but in 0.13% (2/1488) of individuals with aortoiliac or peripheral arterial aneurysms. 35 The current report suggests an even stronger association between SAAs and thoracic aortic disease. At our institution, 925 patients have undergone one or more thoracic aortic operations since 2005, and 19 of these patients harbored an SAA meeting criteria for repair, yielding an incidence of SAA repair of 2.1% in individuals with thoracic aortic pathology requiring surgical repair. In addition, 53% (10/19) of SAA patients in the present series had a history of prior aortic surgery, and 53% (10/19) underwent repair of concomitant thoracic aortic pathology at the time of SAA repair. Thus, practitioners of aortic and vascular surgery should expect to encounter SAAs with some frequency and be familiar with the treatment options for these lesions.
Aneurysmal degeneration of an aberrant subclavian artery was first described by Burckhard F. Kommerell in 1936 and is commonly referred to as "Kommerell's diverticulum." 36 An aberrant RSCA arising from a left-sided aortic arch occurs in 0.5% of the population and is the most common congenital anomaly of the aortic arch. 37 An aberrant LSCA arising from a right-sided aortic arch is 10 times less common and occurs in 0.05% to 0.1% of the population. 38 Reports of aberrant SAAs are restricted largely to case reports or small case series. [37] [38] [39] However, aberrant SAAs may be more unstable than native SAAs and were associated with a 19% to 53% rate of rupture or dissection in prior comprehensive reviews. 37, 40 Aberrant SAAs are well suited to repair by TEVAR as the aneurysmal aberrant subclavian artery is the most distal branch vessel of the aortic arch. Of note, all aberrant SAAs in this series were treated by endovascular methods due to this favorable anatomic configuration. In the setting of an aberrant SAA with a concomitant native SAA, the aberrant and native subclavian arteries neighbor each other on the aorta and are easily treated by bilateral subclavian artery coverage with a single endograft. The TEVAR procedure has previously been used to repair at least nine aberrant SAAs. [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] The present report represents the largest single-institution experience of TEVAR for repair of Kommerell's diverticulum and adds another nine cases to the medical literature.
SAAs are repaired to prevent rupture or treat symptoms of thrombosis, embolization, pain, or local compression. A meta-analysis of 394 native SAAs found that symptoms were present in 84% of patients, with local pain/pulsation, compression of neighboring structures, embolization, rupture, and thrombosis being the most common presenting symptoms, in order of decreasing frequency. Rupture occurred in 9% of patients and carried a mortality rate of 19%. However, the authors were unable to identify a size threshold that was predictive of rupture. In addition, thrombosis was found to occur in smaller SAAs, ranging between 1.2 and 2.5 cm in size. In 2004, Cina et al 40 reviewed all cases of aberrant SAAs occurring with a right-sided aortic arch and found that rupture occurred in SAAs ranging between 2 and 10 cm in size (average 5.8 [2] cm). The authors recommended SAA repair at a size of 3.0 cm; however, this recommendation was based only on the opinion that SAAs are easier to repair when they are small and was not based on statistical analysis. 40 Alternatively, Coselli and Crawford 2 recommended SAA repair whenever feasible, regardless of size, given the high rate of complications. In the present series, we elected to repair SAAs when patients were symptomatic, when patients required operation for other aortic pathology, or when SAA size was >2.0 cm given the unpredictable natural history of SAAs and the documented risk of rupture and thrombosis at this size.
Despite the availability of endovascular repair methods, seven patients with eight SAAs were selected for conventional open repair. Open SAA repair was first attempted unsuccessfully by Mott in 1818 by innominate artery ligation and later successfully by Smyth in 1864 and by Halsted in 1892. 36 Before the endovascular era, contemporary open SAA repair required sternotomy or thoracotomy for access together with cardiopulmonary bypass and hypothermic circulatory arrest in many cases. 1, 2, 37 The most important factors necessitating open repair in the present series included extensive thoracic aortic disease requiring concomitant open repair, CTD, or SAA anatomy not amenable to an endovascular approach. The incidence of SAA may be higher in patients with CTD as it was previously shown that 10% of SAA repairs occurred in patients with CTD. 41 In the present series, 21% of SAA patients had CTD, and 4 of 45 patients with a confirmed diagnosis of CTD undergoing thoracic aortic surgery at our institution during the study period harbored an SAA, for an overall incidence of 9% in this patient population. Failure of endovascular therapy is common in patients with CTD, and we continue to recommend open aneurysm repair whenever feasible in these patients. 42 Endovascular SAA repair has been shown to be associated with a lower rate of cardiopulmonary complications. 1 However, stent grafting within the subclavian artery to exclude SAAs with covered stents has been associated with high rates of short-term thrombosis and failure (0% to 17%) due to compression, deformation, and fracture as a result of the rotationary forces experienced by the subclavian artery and the anatomic location under the clavicle. 1, 36 Proximal SAA inflow exclusion by aortic endografting may therefore be a superior method of endovascular SAA treatment by avoiding the limitations of stent graft placement within the subclavian artery. The present report appears to support this approach by demonstrating a 100% primary technical success rate, 100% primary subclavian artery bypass graft patency, and 91% freedom from reintervention rate with TEVAR-based endovascular repair techniques.
Study limitations. Reports of SAA repair are typically restricted to case reports or small case series. Despite the relatively large patient cohort in the present study, it remains limited by the constraints of sample size, which limits the comparison of findings between procedures as well as with other published reports. In addition, the operations were performed by two principal co-surgeons using standardized techniques, and results may not be generalizable to other practitioners treating different patient populations in different arenas.
CONCLUSIONS
SAAs are rare vascular lesions that require complex operative planning due to numerous anatomic and patientspecific considerations. Modern TEVAR-based endovascular techniques expand SAA repair options with excellent results and allow for less invasive repair of SAAs as well as concomitant thoracic aortic pathology in many patients. The majority of SAAs, and nearly all aberrant SAAs, can now be repaired using a TEVAR-based approach without the need for sternotomy or thoracotomy.
